Applied dna receives linea dna follow-on order from global manufacturer of ivds for cancer diagnostic application

- recurring and accelerated receipt of order reflects customer commitment to linea dna - stony brook, ny / accesswire / september 17, 2024 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced it has received a follow-on order valued at more than $500,000 for a quantity of linea™ dna from a global manufacturer of in vitro diagnostics (ivds). the follow-on order was placed under a long-standing supply agreement for the bulk manufacture of linea dna (non-therapeutic) used in the manufacture of a cancer diagnostic test.
APDN Ratings Summary
APDN Quant Ranking